Home » ETF » BOUT

BOUT - Innovator IBD Breakout Opportunities ETF

Stock Price: $33.52 USD -0.64 (-1.87%)
Updated Apr 20, 2021 4:00 PM EDT - Market closed
Assets $23.98M
NAV $34.25
Expense Ratio 0.84%
PE Ratio 26.51
Beta (5Y) 1.03
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date Dec 27, 2018
1-Year Return -
Trading Day April 20
Last Price $33.52
Previous Close $34.16
Change ($) -0.64
Change (%) -1.87%
Day's Open 33.99
Day's Range 33.39 - 34.10
Day's Volume 11,407
52-Week Range 19.44 - 37.94

Fund Description

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the index). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to break out, or experience a period of sustained price growth beyond the stock's recent resistance level, with consideration for various market conditions. The fund is non-diversified.

Asset Class
Inception Date
Sep 13, 2018
Ticker Symbol
Index Tracked
IBD Breakout Stocks Index

Top 10 Holdings

65.50% of assets
Trex CompanyTREX7.37%
Charles River LaboratoriesCRL7.31%
STAAR SurgicalSTAA7.01%
Installed Building ProductsIBP6.45%
SiteOne Landscape SupplySITE5.81%
Cadence Design SystemsCDNS5.78%
Truist FinancialTFC5.67%
View More Holdings


Solid demand for graphics chips in data centers, Mellanox deal, presence in the video gaming as well as automotive car industries should boost Nvidia-heavy ETFs.

Other tickers mentioned: BOTZ, ESPO, FNGS, HERO, SMH, VIRS
9 months ago - Zacks Investment Research